Ionis Pharmaceuticals IONS Ionis Operations — Segment Reporting Other Item Amount
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's ionis operations — segment reporting other item amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's ionis operations — segment reporting other item amount?
- Ionis Pharmaceuticals (IONS) reported ionis operations — segment reporting other item amount of $18.38M in Q1 2026.
- How has Ionis Pharmaceuticals's ionis operations — segment reporting other item amount changed year-over-year?
- Ionis Pharmaceuticals's ionis operations — segment reporting other item amount decreased by 38.3% year-over-year, from $29.8M to $18.38M.
- What is the long-term trend for Ionis Pharmaceuticals's ionis operations — segment reporting other item amount?
- Over 3 years (2022 to 2025), Ionis Pharmaceuticals's ionis operations — segment reporting other item amount has grown at a 49.2% compound annual growth rate (CAGR), from -$40.21M to $133.58M.
- What does ionis operations — segment reporting other item amount mean?
- Miscellaneous or non-recurring costs and adjustments specific to the segment.
- How do you interpret ionis operations — segment reporting other item amount?
- Large fluctuations may indicate one-time events that distort underlying operational performance.
- How does ionis operations — segment reporting other item amount compare across companies?
- Comparable to other operating income/expense or non-recurring items at peer companies.